Beijing, Aug. 9, 2022——InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced that it will host an earnings conference call and webcast to discuss the 2022 first half year financial results and provide a corporate update at 9:00 a.m. Beijing time on Aug. 22, 2022. Before the call, the Company will announce the first half-year financial results ended June 30, 2022.
Earnings Call and Webcast Information
InnoCare will host an earnings call and webcast on Aug. 22, 2022 at 9:00 a.m. Beijing time. Participants must register in advance of the webcast. Details are as follows:
Register below if you are outside Mainland China:
Register below if you are within Mainland China:
The webcast will be conducted in Chinese.
InnoCare is a commercial stage biopharmaceutical company committed to discovering, developing, and commercializing first-in-class and/or best-in-class drugs for the treatment of cancer and autoimmune diseases. We strategically focus on lymphoma, solid tumors, and autoimmune diseases with high unmet medical needs in China and worldwide. InnoCare has branches in Beijing, Nanjing, Shanghai, Guangzhou, Hong Kong and United States.